#Moderna Merck mRNA cancer vaccine results

Total 1 articles

Microscopic view of mRNA vaccine attacking cancer cells

Moderna Merck mRNA Cancer Vaccine Results: 50 Percent Risk Reduction

Moderna and Merck's mRNA cancer vaccine combined with Keytruda reduced melanoma recurrence risk by 50% in a 5-year study. Read the latest Phase 2 trial insights.

Jan 22, 2026